Evidence map›Paper›PMID 36808887›Full record

ArticleClinical and translational medicine2023

Cefoselis enhances breast cancer chemosensitivity by directly targeting GRP78/LRP5 signalling of cancer stem cells.

Yifeng Zheng, Neng Wang, Shengqi Wang, Bo Pan, Bowen Yang, Juping Zhang, Xuan Wang, Zhiyu Wang

Open access · goldAbstract readLetter
In one paragraph

Article in Clinical and translational medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Yifeng ZhengIntegrative Research Laboratory of Breast Cancer, Discipline of Integrated Chinese and Western Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Neng WangIntegrative Research Laboratory of Breast Cancer, Discipline of Integrated Chinese and Western Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Shengqi WangIntegrative Research Laboratory of Breast Cancer, Discipline of Integrated Chinese and Western Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Bo PanIntegrative Research Laboratory of Breast Cancer, Discipline of Integrated Chinese and Western Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Bowen YangIntegrative Research Laboratory of Breast Cancer, Discipline of Integrated Chinese and Western Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Juping ZhangIntegrative Research Laboratory of Breast Cancer, Discipline of Integrated Chinese and Western Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Xuan WangIntegrative Research Laboratory of Breast Cancer, Discipline of Integrated Chinese and Western Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Zhiyu WangIntegrative Research Laboratory of Breast Cancer, Discipline of Integrated Chinese and Western Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.ORCID 0000-0002-5299-8410
Guangzhou University of Chinese Medicine · CN

Funding

Bajian Talents of Guangdong Provincial Hospital of Chinese Medicine BJ2022KY12Bajian Talents of Guangdong Provincial Hospital of Chinese Medicine BJ2022KY18Department of Education of Guangdong Province 2018KZDXM022Department of Education of Guangdong Province 2019KQNCX019Department of Education of Guangdong Province A1-2606-19-111-009Foundation for Young Scholars of Guangzhou University of Chinese Medicine QNYC20190101Guangdong Medical Research Foundation 20201119103046743Guangdong Provincial Science and Technology Innovation Strategy Special Fund (Guangdong-Hong Kong-Macau Joint Lab) 2020B1212030006Guangdong Science and Technology Department 2016A030306025Guangzhou Science and Technology Project 201904010407Guangzhou Science and Technology Project 202102010241Guangzhou Science and Technology Project 202102010316National Natural Science Foundation of China 81873306National Natural Science Foundation of China 81973526National Natural Science Foundation of China 82004132National Natural Science Foundation of China 82004373National Natural Science Foundation of China 82074165National Natural Science Foundation of China 82174165Science and Technology Planning Project of Guangdong Province 2017B030314166Science and Technology Planning Project of Guangdong Province 2021A0505030059State Key Laboratory of Dampness Syndrome of Chinese Medicine SZ2021ZZ19TCM Science and Technology of Guangdong provincial Hospital of Chinese Medicine YN2018MJ07TCM Science and Technology of Guangdong provincial Hospital of Chinese Medicine YN2018QJ08Traditional Chinese Medicine Bureau of Guangdong Province 20201132Traditional Chinese Medicine Bureau of Guangdong Province 20211114Traditional Chinese Medicine Bureau of Guangdong Province 20212085Traditional Chinese Medicine Bureau of Guangdong Province 20225011
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Breast NeoplasmsCeftizoximeEndoplasmic Reticulum Chaperone BiPFemaleHumansLow Density Lipoprotein Receptor-Related Protein-5Neoplastic Stem CellscefoselisCeftizoximeEndoplasmic Reticulum Chaperone BiPLow Density Lipoprotein Receptor-Related Protein-5LRP5 protein, human

Identifiers

PMID36808887
PMCPMC9939292
OpenAlexW4321350766

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.